Prisma Health, Institute for Translational Oncology Research, Clinical Research Unit — Greenville, South Carolina

Prisma Health, Institute for Translational Oncology Research, Clinical Research Unit is a clinical research site located in Greenville, South Carolina, United States 29605.

Crixeo Health Trust Score: 47/100 (POOR). This profile has not yet been claimed by the site owner.

Prisma Health, Institute for Translational Oncology Research, Clinical Research Unit has participated in 1 clinical trials.

Therapeutic areas: Lymphoma, Multiple Myeloma, Acute Myeloid Leukemia.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 47/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Prisma Health, Institute for Translational Oncology Research, Clinical Research Unit?

Prisma Health, Institute for Translational Oncology Research, Clinical Research Unit has a Crixeo Trust Score of 47/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Prisma Health, Institute for Translational Oncology Research, Clinical Research Unit conducted?

Prisma Health, Institute for Translational Oncology Research, Clinical Research Unit has 1 clinical trials on record. Their work covers Lymphoma, Multiple Myeloma, Acute Myeloid Leukemia.

Is Prisma Health, Institute for Translational Oncology Research, Clinical Research Unit accredited by Crixeo Health?

Prisma Health, Institute for Translational Oncology Research, Clinical Research Unit has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Prisma Health, Institute for Translational Oncology Research, Clinical Research Unit?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.